WEYMIN HAGO: Open Payments
NPI 1992941314 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 73 payments from 17 companies in 2025. Trend: 2023 $782 · 2024 $940 · 2025 $1,589
Food & beverage: $1,589
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 18 | $275 |
| AstraZeneca Pharmaceuticals LP | 9 | $162 |
| PFIZER INC. | 7 | $154 |
| ViiV Healthcare Company | 6 | $143 |
| Lilly USA, LLC | 5 | $132 |
| Novo Nordisk Inc | 5 | $118 |
| SHIELD THERAPEUTICS INC | 5 | $114 |
| Antares Pharma, Inc. | 3 | $96 |
| Exact Sciences Corporation | 3 | $94 |
| Amgen Inc. | 3 | $63 |
Products named: NURTEC ODT, APRETUDE, Ozempic, ACCRUFER, MOUNJARO, XYOSTED, AIRSUPRA, REXULTI.
Industry payments across NY — which companies pay providers there.
